See at a glance what Vernalis has in development

See the status of all programmes, both partnered and un-partnered.

Explore NCE Pipeline

We have two programmes in CNS both focussed on pain management

Central Nervous System

We have six programmes in Oncology

Four partnered and two available for out-licensing

Oncology

We have a single programme focussed on inflammation which is partnered

Inflammation

Subcategories

At a glance

More information on Vernalis and its pipeline ...

FactsheetNov14 Company fact sheet

Comm thumbnail Explore the pipeline ...

Contact Vernalis

T: 0118 938 0000
F: 0118 938 0001

Contact information
Maps and directions
Contact form

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. at 1-855-705-9546 and drugsafety@propharmagroup.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch